Inhibikase Therapeutics | 4:持股变动声明-董事 GRINT PAUL C
Inhibikase Therapeutics | 4:持股变动声明-董事 Dion Gisele
Inhibikase Therapeutics | 4:持股变动声明-董事 BERMAN DENNIS N
Inhibikase Therapeutics | 4:持股变动声明-董事 Freeman Roy Lester
Inhibikase Therapeutics | D:发行公告
Inhibikase Therapeutics | 4:持股变动声明-高管 Werner Milton H.
Inhibikase Therapeutics | 4:持股变动声明-高管 Lees-Rolfe Garth
Inhibikase Therapeutics | 3:首次持股声明-高管 Lees-Rolfe Garth
Inhibikase Therapeutics | 4:持股变动声明-董事 BERMAN DENNIS N
Inhibikase Therapeutics | 4:持股变动声明-董事 Dion Gisele
Inhibikase Therapeutics | 4:持股变动声明-董事 GRINT PAUL C
Inhibikase Therapeutics | 4:持股变动声明-董事 Freeman Roy Lester
Inhibikase Therapeutics | 4:持股变动声明-高管 Werner Milton H.
Inhibikase Therapeutics | 4:持股变动声明-高管 FRATTAROLI JOSEPH
Inhibikase Therapeutics | SC 13D:超过5%持股股东披露文件-FiveT Investment Management Ltd(4.78%),FiveT Capital AG(4.78%)
Inhibikase Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Milton H. Werner(19.68%)
Inhibikase Therapeutics | D:发行公告
Inhibikase Therapeutics | SC 13D:超过5%持股股东披露文件-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)
Inhibikase Therapeutics | 4:持股变动声明
Inhibikase Therapeutics | 3:首次持股声明-董事 Dion Gisele
暂无数据
暂无数据